Predicting The Future Of Medications—More Options & More Medication Adherence

A couple of months ago, we wrote about the recent approvals by the U.S. Federal Drug Administration (FDA) for innovative apps and medical devices in the complex consumer space (see The Emerging Digital Treatment Era). But there is also an impressive list of approved and soon-to-be-approved novel medications and new medication formulations. Keeping an eye on this pipeline of innovations is important for executives of payers, health plans, and provider organizations alike. Medications are now 10% of U.S. health care spending and integral to many care management plans.

To look at the new medications for . . .